Loading...
1933 Industries Inc.
TGIFF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.004
$-0.00(-42.78%)
1933 Industries Inc. (TGIFF) Financial Performance & Statements
Review 1933 Industries Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
5.90%
↑ 5.90%
Operating Income Growth
100.00%
↑ 100.00%
Net Income Growth
91.45%
↑ 91.45%
Operating Cash Flow Growth
210.77%
↑ 210.77%
Operating Margin
12.61%
↑ 12.61%
Gross Margin
16.31%
↑ 16.31%
Net Profit Margin
-3.01%
↓ 3.01%
ROE
13.10%
↑ 13.10%
ROIC
19.11%
↑ 19.11%
1933 Industries Inc. (TGIFF) Financial Statements
Explore quarterly and annual reports for 1933 Industries Inc. stock.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $4.41M | $3.99M | $4.23M | $4.87M |
| Cost of Revenue | $2.90M | $2.69M | $6.71M | $3.30M |
| Gross Profit | $1.51M | $1.31M | -$2.49M | $1.56M |
| Gross Profit Ratio | $0.34 | $0.33 | -$0.59 | $0.32 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $503141.00 | $701065.00 | $550172.00 | $935796.00 |
| Operating Expenses | $797730.00 | $749850.00 | -$2.49M | $935796.00 |
| Total Costs & Expenses | $3.70M | $3.44M | $4.23M | $4.24M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $582872.00 | $840824.00 | $0.00 | $486014.00 |
| Depreciation & Amortization | $265530.00 | $258498.00 | $538357.00 | $655538.00 |
| EBITDA | $535031.00 | $521493.00 | -$1.58M | $1.22M |
| EBITDA Ratio | $0.12 | $0.13 | -$0.37 | $0.25 |
| Operating Income | $714552.00 | $557589.00 | $0.00 | $627630.00 |
| Operating Income Ratio | $0.16 | $0.14 | $0.00 | $0.13 |
| Other Income/Expenses (Net) | -$1.03M | -$1.14M | -$1.21M | -$545451.00 |
| Income Before Tax | -$313370.00 | -$577829.00 | -$1.21M | $82179.00 |
| Income Before Tax Ratio | -$0.07 | -$0.14 | -$0.29 | $0.02 |
| Income Tax Expense | $0.00 | $0.00 | -$1.63M | $0.00 |
| Net Income | -$328033.00 | -$587031.00 | $8575.00 | $16694.00 |
| Net Income Ratio | -$0.07 | -$0.15 | $0.002 | $0.003 |
| EPS | -$0.001 | -$0.001 | $0.00 | $0.00 |
| Diluted EPS | -$0.001 | -$0.001 | $0.00 | $0.00 |
| Weighted Avg Shares Outstanding | $490.47M | $490.47M | $490.47M | $490.47M |
| Weighted Avg Shares Outstanding (Diluted) | $490.47M | $490.47M | $490.47M | $490.47M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan